Label reference · Respiratory & allergy
Breo Ellipta (Fluticasone Furoate And Vilanterol Trifenatate) Powder — label reference
DailyMed · Retrieved 2026-10-13
Breo Ellipta is listed in DailyMed as powder. Active ingredients: fluticasone furoate; vilanterol trifenatate. This reference records product facts and version 29; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- Breo Ellipta
- Generic product name
- fluticasone furoate and vilanterol trifenatate
- Active ingredient
- FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
- Dosage form
- POWDER
- Route
- RESPIRATORY (INHALATION)
- SPL author / labeler
- GlaxoSmithKline LLC
- SPL version
- 29
- Published on DailyMed
- 2026-06-08
- SPL effective date
- 2024-11-07
- SPL set ID
- 96428df1-ea05-431a-98d3-1ec2c4b63878
Product identity
Product name: Breo Ellipta
Generic name: fluticasone furoate and vilanterol trifenatate
Active ingredients: FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
Dosage form: POWDER
Route: RESPIRATORY (INHALATION)
Label version
DailyMed published this record on 2026-06-08. SPL version: 29. Set ID: 96428df1-ea05-431a-98d3-1ec2c4b63878. The SPL effective date is 2024-11-07.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-06-08. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.